- Country: Netherlands
- Summary: Pcp Innovation Challenge Decentralized Test Innovations T.b.v. Pandemic Readiness by Pathogenic Detection (p3dx)
- NLT Ref No: 114101183
- Deadline: 24 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: WS2382545568
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The Innovation Challenge P3DX focuses on the development of innovative, lab -dependent tests that can be used in both future pandemic situations and for non -landemic applications. The aim is to stimulate a robust value chain of decentralized test innovations - from production to data access - and thus contributing to better readiness and broader employability of test technologies.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPcp Innovation Challenge Decentralized Test Innovations T.b.v. Pandemic Readiness by Pathogenic Detection (p3dx) - Netherlands Tender
The DUTCH ORGANIZATION FOR APPLIED-NATURAL RESEARCH TNO, a Government sector organization in Netherlands, has announced a new tender for Pcp Innovation Challenge Decentralized Test Innovations T.b.v. Pandemic Readiness by Pathogenic Detection (p3dx). This tender is published on NetherlandsTenders under NLT Ref No: 114101183 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-24.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
